PAHO to use revolving fund to better region’s access to COVID-19 vaccines

The Pan American Health Organisation (PAHO) is expected to begin procuring COVID-19 vaccines in an attempt to improve access to vaccines in Latin America and the Caribbean.

In a media release on Wednesday, PAHO noted that the procurement of the vaccines will come through the use of PAHO’s Revolving Fund. The revolving fund is expected to expand access beyond the 20 per cent of vaccines that the COVAX facility offers.

The fund has procured other vaccines for the region for the past 42 years at low prices and as a result of the announcement is receiving requests from countries to have COVID-19 vaccines for the last three months of 2021 and for 2022.